Particulate Matter Air Pollution Linked To Vision Loss: Study

The findings of a new study indicates exposure to particulate matter in air pollution may increase the risk of macular degeneration, and related vision loss.

Age-related macular degeneration is an irreversible type of progressive blindness, which researchers indicate may be 8% more likely to occur among those with the highest pollution exposure of fine particulate matter, according to the findings published last month in the British Journal of Ophthalmology.

Researchers from the U.S. and U.K. conducted a cross-sectional study which included more than 115,000 UK Biobank participants ages 40 to 69 years old, with no eye problems at the beginning of the study.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The study assessed self-reported age-related macular degeneration diagnoses and measures of retinal sublayer thickness, which is a structural change in the thickness or numbers of light receptors in the retina.

Ambient air pollution measures included particulate matter, nitrogen dioxide and nitrogen oxides. Estimates were provided by the Small Area Health Statistics Unit as part of the BioShaRE-EU Environmental Determinants of Health Project. Official information on traffic, land use, and topography was used to calculate the annual average air pollution levels at participants home addresses.

Individuals with exposure to higher levels of particulate matter (PM 2.5) air pollution and nitrogen dioxide were found to have thicker inner and outer segment layers of the retina and thinner retinal pigment epithelium layer. These types of changes to the eye are linked to progressive and irreversible vision loss known as age-related macular degeneration.

PM 2.5 is air pollution particles the size of 2.5 micrometers or smaller, or roughly 70 times smaller than one human hair. These are a mixture of soot and dirt so small that the particles are easily inhaled into the lungs and move to the blood stream, leading to health side effects.

Researchers indicated exposure to PM 2.5 air pollution increased the risk of macular degeneration by 8% in the most polluted areas. Even at low exposure levels, the risk of age-related macular degeneration was increased.

Prior research indicates exposure to particulate matter air pollution increases the risk of early death, even at levels below national safety standards. Short-term exposure can lead to other health side effects, such as increased risk of cardiac arrest.

In this latest study, higher levels of PM 10 were linked with thicker photoreceptor outer segment and thinner retinal pigment epithelium layer. Higher exposure to nitrogen oxides was liked to thinner photoreceptor synaptic region. Both changes that can lead to vision loss.

“Greater exposure to PM 2.5 was associated with self-reported age-related macular degeneration, while PM 2.5, PM 2.5 absorbance, PM 10, nitrogen dioxide and nitrogen oxides were all associated with differences in retinal layer thickness,” the researchers noted.

The findings suggest air pollution is an important, but modifiable risk factor affecting eye disease which may lead to loss of eyesight.

The research does not prove cause and effect but suggests an association between particulate matter and macular degeneration. However, researchers speculate age-related macular degeneration caused by air pollution may be linked through oxidative stress or inflammation caused by structural changes linked to air pollution exposure.

In high-income countries, age-related macular degeneration is the leading cause of irreversible blindness among people over 50. Nearly 300 million people will be affected by the condition by 2040.

Air pollution, especially exposure to particulate matter, leads to the deaths of more than 30,000 Americans each year and is linked to neurological disorders later in life, such as Alzheimer’s disease and dementia.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.